Last update Oct. 22, 2016
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
C13H11ClN2O2 belongs to this group or family:
Main tradenames from several countries containing C13H11ClN2O2 in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 75 | % |
Molecular weight | 263 | daltons |
Protein Binding | 96 - 98 | % |
VD | 0.3 | l/Kg |
Tmax | 0.5 - 0.8 | hours |
T½ | 1.4 - 1.9 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by IHAN of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
A fecha de última actualización no encontramos datos publicados sobre su excreción en leche materna.
Sus datos farmacocinéticos (elevado porcentaje de fijación a proteínas y corta vida media) hacen poco probable el paso a leche de cantidades significativas.
Hasta conocer más datos publicados sobre este fármaco en relación con la lactancia, pueden ser preferibles alternativas conocidas más seguras, especialmente durante el periodo neonatal y en caso de prematuridad.